Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 46 min 14 sec ago

Intuitive Surgical to Begin Direct Sales of da Vinci(R) Surgical Systems in Japan

Wed, 07/02/2014 - 15:28
SUNNYVALE, Calif., July 1, 2014 -- (Healthcare Sales & Marketing Network) -- Intuitive Surgical (ISRG) and Adachi Co. Ltd. today announced an agreement to transition Japanese sales, marketing, service, support and training for da Vinci(R) Systems, instrume...
Devices, Surgery, Distribution
Intuitive Surgical, da Vinci, robotic surgery

Alere Announces Management Transition

Tue, 07/01/2014 - 13:49
Ron Zwanziger Resigns as Chief Executive Officer and President; Namal Nawana Appointed Interim CEO WALTHAM, Mass., July 1, 2014 -- (Healthcare Sales & Marketing Network) -- Alere Inc. (ALR), a global leader in empowering individuals to take greater con...
Devices, Monitoring, Personnel
Alere Inc

Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO

Tue, 07/01/2014 - 13:00
BOSTON, July 1, 2014 -- (Healthcare Sales & Marketing Network) -- Paratek Pharmaceuticals, Inc., today announced that Michael F. Bigham, Partner at Abingworth LLP, has been appointed as Chairman of the Board of Directors and Chief Executive Officer. In add...
Biopharmaceuticals, Personnel
Paratek Pharmaceuticals

Ipsen submits marketing authorization applications in the US and Europe for Somatuline(R) (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Tue, 07/01/2014 - 12:55
Supplemental New Drug Application submitted to the U.S. Food and Drug Administration Marketing authorization variations submitted in 25 countries of the European Union PARIS--(Healthcare Sales & Marketing Network)--Ipsen (Euronext: IPN; ADR: IPSEY) t...
Biopharmaceuticals, Oncology
Ipsen, Somatuline, lanreotide, GEP-NET

Stryker Announces Definitive Agreement to Acquire Assets of Small Bone Innovations, Inc.

Mon, 06/30/2014 - 15:47
Kalamazoo, Michigan - June 30, 2014 -- (Healthcare Sales & Marketing Network) -- Stryker Corporation (SYK) announced today a definitive agreement to acquire assets of Small Bone Innovations, Inc. ("SBi") in an all cash transaction for up to $375 ...
Devices, Orthopaedic, Acquisitions
Stryker, Small Bone Innovations, total ankle replacement

Benvenue Medical Expands Senior Management Team

Mon, 06/30/2014 - 15:43
Jeffrey Jones Joins as Chief Operating Officer SANTA CLARA, Calif., June 30, 2014 -- (Healthcare Sales & Marketing Network) -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that Jeffrey Jones has ...
Devices, Orthopaedic, Neurosurgery, Personnel
Benvenue Medical, VCF Treatment System

Stryker Corporation To Acquire Small Bone Innovations

Mon, 06/30/2014 - 15:40
MORRISVILLE, Pa.--(Healthcare Sales & Marketing Network)--Small Bone Innovations, Inc. (SBi) today announced that Stryker Corporation (SYK) will acquire substantially all the assets of SBi in an all cash transaction for up to $375 million. The transacti...
Devices, Orthopaedic, Mergers & Acquisitions
Small Bone Innovations, Stryker, Total Ankle

Allergan Announces RandD Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET

Mon, 06/30/2014 - 15:37
Announces Positive Phase 2 Data for Abicipar Pegol (Anti-VEGF DARPin®) and Advances to Phase 3 Trials Advances Bimatoprost Sustained-Release Implant for Glaucoma to Phase 3 Trials Receives FDA Approval for OZURDEX® (dexamethasone intravitreal...
Biopharmaceuticals, Ophthalmology, FDA
Allergan, OZURDEX, dexamethasone, intravitreal implant, diabetic macular edema

Cidara Therapeutics Completes $32 Million Series A Financing

Mon, 06/30/2014 - 13:33
Veteran team to apply novel, small molecule immunotherapy platform to treat severe fungal infections in immune compromised patients SAN DIEGO, Calif.--(Healthcare Sales & Marketing Network)--Cidara Therapeutics, Inc., a privately held biopharmaceutical ...
Biopharmaceuticals, Personnel
Cidara Therapeutics

Baxano Surgical Announces First Clinical Use of the Avance MIS Pedicle Screw System

Mon, 06/30/2014 - 13:27
RALEIGH, N.C., June 30, 2014 -- (Healthcare Sales & Marketing Network) -- Baxano Surgical, Inc. (BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine...
Devices, Neurosurgery, Orthopaedic
Baxano Surgical, Avance MIS, Pedicle Screw, spine surgery

Titan Medical Inc. Corporate Update

Mon, 06/30/2014 - 13:23
TORONTO, ONTARIO--(Healthcare Sales & Marketing Network) - Titan Medical Inc. (the "Company") (TSX VENTURE:TMD) (TITXF) announced today that Mr. Joe Talarico, Senior Vice President Business Development has resigned his position with the Company. ...
Devices, Surgery, Personnel
Titan Medical, robotic surgery

InSightec Announces a New Series D Funding of $50 Million to Accelerate Market Development of MR-Guided Focused Ultrasound Noninvasive Treatments

Mon, 06/30/2014 - 13:15
TIRAT CARMEL, Israel, June 30, 2014 -- (Healthcare Sales & Marketing Network) -- InSightec, the global leader and pioneer in MR-guided focused ultrasound (MRgFUS) therapy for the non-invasive treatment of tumors, announced today that it is raising $50 mil...
Devices, Venture Capital
InSightec, MR-guided focused ultrasound, MRgFUS

Flamel Technologies Announces FDA Approval of VAZCULEP

Mon, 06/30/2014 - 13:10
LYON, FRANCE--(Healthcare Sales & Marketing Network) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for VAZCULEP™ (phenylephrine hydrochloride). VA...
Biopharmaceuticals, FDA
Flamel Technologies, VAZCULEP, phenylephrine hydrochloride

Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer

Mon, 06/30/2014 - 13:06
CAMBRIDGE, MA--(Healthcare Sales & Marketing Network) - Proteostasis Therapeutics, Inc., a developer of novel therapeutics regulating protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, today announced the appoi...
Biopharmaceuticals, Personnel
Proteostasis Therapeutics

CHMP Recommends EU Approval of VIZAMYL(TM) (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque

Mon, 06/30/2014 - 12:59
PET Imaging Agent Receives Positive Opinion CHALFONT ST. GILES, England--(Healthcare Sales & Marketing Network)--GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Hu...
Biopharmaceuticals, Radiology, Neurology, Regulatory
GE Healthcare, VIZAMYL, Flutemetamol F18, PET , Alzheimer’s disease, imaging

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong